Literature DB >> 17012676

Medication-induced weight gain and dyslipidemia in patients with schizophrenia.

Wayne S Fenton1, Mark R Chavez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17012676     DOI： 10.1176/ajp.2006.163.10.1697

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

1.  Physician styles of decision-making for a complex condition: Type 2 diabetes with co-morbid mental illness.

Authors:  Felicia L Trachtenberg; David M Pober; Lisa C Welch; John B McKinlay
Journal:  Eur J Pers Cent Healthc       Date:  2014

Review 2.  Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes.

Authors:  Lior Greenbaum; Bernard Lerer
Journal:  Front Neurol       Date:  2015-02-20       Impact factor: 4.003

3.  Prevalence and Associated Factors of Metabolic Syndrome among Patients with Severe Mental Illness Attending a Tertiary Hospital in Southwest Uganda.

Authors:  David Collins Agaba; Richard Migisha; Rosemary Namayanja; Godfrey Katamba; Henry Mark Lugobe; Hillary Aheisibwe; Godfrey Twesigomwe; Scholastic Ashaba
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

4.  Relationship between obesity and antipsychotic drug use in the adult population: a longitudinal, retrospective claim database study in Primary Care settings.

Authors:  Antoni Sicras-Mainar; Ruth Navarro-Artieda; Javier Rejas-Gutiérrez; Milagrosa Blanca-Tamayo
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.